Mehmet Nuri Başer

6PUBLICATIONS
50CO-AUTHORS
Predictive and prognostic markersOptical technologyCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jul 15, 2026
Prognostic Impact of Immune-Inflammatory and Nutritional Indices in Metastatic Hormone-Sensitive Prostate Cancer.

|May 13, 2026
Pretreatment Lactate Dehydrogenase-to-Albumin Ratio and Clinical Outcomes in Extensive-Stage Small Cell Lung Cancer: A Multicenter Real-World Study.

|May 13, 2026
Uric Acid-Driven Biomarkers and Clinical Outcomes in Metastatic Pancreatic Cancer: A Multicenter Real-World Cohort Study.

|Feb 13, 2026
Real-World Treatment Patterns and Survival in Uveal Melanoma: A Multicenter Cohort Study by the Turkish Oncology Group (TOG).

Sercan On, Selin Cebeci, Zeynep Hande Turna

|Jul 30, 2025
Impact of Treatment Duration in First-Line Atezolizumab Plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer: A Multicenter Real-World Retrospective Study.

Mehmet Nuri Baser, Bilgin Demir, Gamze Serin Ozel

|May 06, 2021
Is CONUT score a prognostic index in patients with diffuse large cell lymphoma?

Gülsüm Akgün Çağlıyan, Sibel Hacıoğlu, Başak Ünver Koluman

Pageof 1

Frequent Collaborators

4 joint publications

Ahmet Unlu

3 joint publications

Asim Armagan Aydin

2 joint publications

Banu Ozturk

2 joint publications

Bilgin Demir